CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Return
8.35%
This Quarter Return
+2.13%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$1.21B
AUM Growth
+$77.3M
(+6.8%)
Cap. Flow
+$64.9M
Cap. Flow
% of AUM
5.34%
Top 10 Holdings %
Top 10 Hldgs %
46.34%
Holding
331
New
34
Increased
189
Reduced
69
Closed
18
Top Buys
| 1 |
NVIDIA
NVDA
|
$22.5M |
| 2 |
Neumora Therapeutics
NMRA
|
$4.48M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$3.81M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
$3.64M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
$3.54M |
Top Sells
Sector Composition
| 1 | Technology | 7.76% |
| 2 | Healthcare | 2.78% |
| 3 | Financials | 1.79% |
| 4 | Communication Services | 1.44% |
| 5 | Consumer Discretionary | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
USBC
301
USBC, Inc.
USBC
$323M
| $152K | 0.01% |
9,250
| – | – |
|
302
Cardiff Oncology
CRDF
$144M
| $144K | 0.01% |
65,047
+22,300
| +52% | +$49.5K |
|
303
Haleon
HLN
$43.9B
| $137K | 0.01% |
16,598
+4,319
| +35% | +$35.7K |
|
|
CIO
304
City Office REIT
CIO
$280M
| $132K | 0.01% |
26,484
| – | – |
|
305
Telefonica
TEF
$30.1B
| $124K | 0.01% |
29,352
+5,792
| +25% | +$24.4K |
|
306
NatWest
NWG
$55.4B
| $96.8K | 0.01% |
+12,058
| New | +$96.8K |
|
307
ImmunityBio
IBRX
$2.27B
| $76.2K | 0.01% |
12,055
+1,500
| +14% | +$9.48K |
|
308
Equillium
EQ
$114M
| $69.1K | 0.01% |
99,688
| – | – |
|
|
OPI
309
Office Properties Income Trust
OPI
$16.7M
| $63.8K | 0.01% |
31,250
| – | – |
|
310
Grab
GRAB
$21B
| $60.7K | 0.01% |
17,097
+6,176
| +57% | +$21.9K |
|
311
Allogene Therapeutics
ALLO
$255M
| $49.1K | ﹤0.01% |
21,089
| – | – |
|
312
Dyadic International
DYAI
$32.9M
| $40.2K | ﹤0.01% |
27,174
| – | – |
|
313
Ventyx Biosciences
VTYX
$180M
| $37.7K | ﹤0.01% |
16,310
| – | – |
|
314
Bristol-Myers Squibb
BMY
$96B
| – | – |
-5,718
| Closed | -$310K |
|
315
British American Tobacco
BTI
$122B
| – | – |
-8,777
| Closed | -$268K |
|
316
Cidara Therapeutics
CDTX
$1.6B
| – | – |
-4,758
| Closed | -$87.6K |
|
317
Cigna
CI
$81.5B
| – | – |
-712
| Closed | -$259K |
|
318
CVS Health
CVS
$93.6B
| – | – |
-2,681
| Closed | -$214K |
|
319
ICL Group
ICL
$7.85B
| – | – |
-11,192
| Closed | -$60.2K |
|
320
Illumina
ILMN
$15.7B
| – | – |
-1,617
| Closed | -$216K |
|
321
Kroger
KR
$44.8B
| – | – |
-3,737
| Closed | -$213K |
|
322
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$3.77B
| – | – |
-7,240
| Closed | -$255K |
|
323
Ryanair
RYAAY
$32.1B
| – | – |
-3,440
| Closed | -$200K |
|
324
iShares MSCI EAFE Small-Cap ETF
SCZ
$10.7B
| – | – |
-3,524
| Closed | -$223K |
|
325
SPDR Portfolio Emerging Markets ETF
SPEM
$13.3B
| – | – |
-6,000
| Closed | -$217K |
|